New European Patient Guidelines Launched on NAFLD

New European Patient Guidelines Launched on NAFLD

EASO is pleased to share this new set of patient guidelines developed collaboratively across Europe by experts in Hepatology and intended for all patients at risk of, or currently living with non-alcoholic fatty liver disease (NAFLD).

NAFLD is the most frequent chronic liver disease worldwide yet there is a lack of awareness about the causes and consequences of NAFLD among both patients and HCPs. NAFLD management requires close interaction between patients and their healthcare providers. 

Congratulations to EASL on hosting the Digital NAFLD Summit 2021 The new NAFLD Patient Guidelines are also shared in the context of the Summit. 

Learn more and read the guidelines: